On December 14, 2022, Medifron DBT Co., Ltd. closed the transaction. The company issued 3,427,600 shares in the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,206 KRW | +1.26% | +3.61% | -27.91% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1,480 KRW | +3.93% | +13.85% | 67.55M | ||
1,206 KRW | +1.26% | +3.61% | 59.71M | ||
1st Jan change | Capi. | |
---|---|---|
-27.91% | 59.71M | |
-14.64% | 188B | |
+1.84% | 166B | |
+0.24% | 151B | |
+3.85% | 101B | |
+5.59% | 77.06B | |
+18.38% | 71.46B | |
-8.33% | 70.46B | |
-20.85% | 52.14B | |
-7.19% | 44.34B |
- Stock Market
- Equities
- A057680 Stock
- News T Scientific Co.,Ltd.
- Medifron DBT Co., Ltd. announced that it has received KRW 4.0000092 billion in funding from T Scientific Co.,Ltd